APSR2026-636

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP08-011
P66
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1221018-46904-APSR2026_Poster.pdf_433773.pdf
Format: PDF Only
06. Tuberculosis
2

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Inayah Syech Abubakar * Ulin General Hospital Faculty of Medicine and Health Science, Lambung Mangkurat University Banjarmasin Indonesia
Mohamad Isa - Ulin General Hospital Faculty of Medicine and Health Science, Lambung Mangkurat University Banjarmasin Indonesia
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Inayah
Syech Abubakar
nayaabubakar@gmail.com
+6281241110069
31-40
Indonesia
Original Research
Epidemiological characteristics and risk factors of drug-resistant pulmonary tuberculosis at Ulin General Hospital Banjarmasin
Maximum 25 words
Abstract Content
Drug-resistant tuberculosis (DR-TB) remains a major global health problem due to prolonged treatment duration, significant adverse effects, and treatment outcomes. Local data are essential to describe epidemiological characteristics and risk factors influencing treatment success. Ulin General Hospital, as a referral hospital in South Kalimantan, plays a vital role in the management of DR-TB; however, data regarding the epidemiological characteristics, risk factors and case distribution of patients remain limited. Therefore, this study aimed to support support evidence-based regional prevention and management strategies.
This was a retrospective descriptive observational study using medical records and the Tuberculosis Information System registry at Ulin General Hospital from 2020 to 2025. A total of 92 DR-TB patients met the inclusion criteria. Variables included age, sex, nutritional status, comorbidities, history of tuberculosis treatment, resistance patterns, treatment regimens, as well as treatment outcomes and sputum conversion.
Of 178 DR-TB patients, 92 met the inclusion criteria. Most were male (60.9%) and aged 40–59 years (54.4%). Rifampicin-resistant tuberculosis was predominant (66.3%), followed by multidrug-resistant tuberculosis (26.1%) and pre-extensively drug-resistant tuberculosis (7.6%). The most common regimens were short-course therapy (53.3%) and BPaLM (31.5%). More than half of patients were underweight (55.4%), and 27.2% had diabetes mellitus, while HIV prevalence was low (1.1%). Previous tuberculosis treatment was reported in 32.4%, mostly relapse cases. Treatment success was achieved in 81.5% of patients, while 18.5% were lost to follow-up. Among patients with initial positive smears, 87.5% achieved sputum conversion, mostly within the first two months, with reversion observed in 12.5%.
Treatment outcomes in DR-TB are relatively favorable; however, challenges such as loss to follow-up and reversion remain. Nutritional status, comorbidities, and treatment adherence play key roles, highlighting the need for comprehensive strategies including patient education, nutritional support, and continuous monitoring to improve treatment success.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Drug-resistant tuberculosis, risk factors, treatment outcomes
maximum 3 keywords and no abbreviations, separated by commas
The authors declare no conflicts of interest. No financial support was received for this study. The authors would like to extend their deepest appreciation to all individuals and institutions who contributed to the completion of this mini research.
306